Zobrazeno 1 - 7
of 7
pro vyhledávání: '"den Hartog IJ"'
Autor:
Bate-Eya LT; Department of Oncogenomics, University of Amsterdam, Amsterdam, The Netherlands., den Hartog IJ; Department of Oncogenomics, University of Amsterdam, Amsterdam, The Netherlands., van der Ploeg I; Department of Oncogenomics, University of Amsterdam, Amsterdam, The Netherlands., Schild L; Department of Oncogenomics, University of Amsterdam, Amsterdam, The Netherlands., Koster J; Department of Oncogenomics, University of Amsterdam, Amsterdam, The Netherlands., Santo EE; Department of Oncogenomics, University of Amsterdam, Amsterdam, The Netherlands., Westerhout EM; Department of Oncogenomics, University of Amsterdam, Amsterdam, The Netherlands., Versteeg R; Department of Oncogenomics, University of Amsterdam, Amsterdam, The Netherlands., Caron HN; Department of Pediatric Oncology, Emma Kinderziekenhuis, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Molenaar JJ; Department of Oncogenomics, University of Amsterdam, Amsterdam, The Netherlands., Dolman ME; Department of Oncogenomics, University of Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Oncotarget [Oncotarget] 2016 May 10; Vol. 7 (19), pp. 27946-58.
Autor:
Dolman ME; Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. memdolman@gmail.com., Poon E; Division of Clinical Studies, The Institute of Cancer Research, London, England., Ebus ME; Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., den Hartog IJ; Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., van Noesel CJ; Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Jamin Y; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, England., Hallsworth A; Division of Clinical Studies, The Institute of Cancer Research, London, England., Robinson SP; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, England., Petrie K; Division of Clinical Studies, The Institute of Cancer Research, London, England., Sparidans RW; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands., Kok RJ; Division of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, the Netherlands., Versteeg R; Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Caron HN; Department of Pediatric Oncology, Emma Kinderziekenhuis, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Chesler L; Division of Clinical Studies, The Institute of Cancer Research, London, England., Molenaar JJ; Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2015 Nov 15; Vol. 21 (22), pp. 5100-9. Date of Electronic Publication: 2015 Jul 22.
Autor:
Dolman ME; Amsterdam Medical Center, University of Amsterdam, Department of Oncogenomics, Meibergdreef 15, PO Box 22700, 1105 AZ Amsterdam, The Netherlands., den Hartog IJ; Amsterdam Medical Center, University of Amsterdam, Department of Oncogenomics, Meibergdreef 15, PO Box 22700, 1105 AZ Amsterdam, The Netherlands., Molenaar JJ; Amsterdam Medical Center, University of Amsterdam, Department of Oncogenomics, Meibergdreef 15, PO Box 22700, 1105 AZ Amsterdam, The Netherlands., Schellens JH; Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology & Clinical Pharmacology, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands; The Netherlands Cancer Institute, Department of Clinical Pharmacology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Beijnen JH; Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology & Clinical Pharmacology, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands; The Netherlands Cancer Institute, Department of Clinical Pharmacology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Slotervaart Hospital, Department of Pharmacy & Pharmacology, Louwesweg 6, 1066 EC Amsterdam, The Netherlands., Sparidans RW; Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology & Clinical Pharmacology, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. Electronic address: R.W.Sparidans@uu.nl.
Publikováno v:
Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2014 Apr; Vol. 92, pp. 144-8. Date of Electronic Publication: 2014 Jan 21.
Autor:
Bate-Eya LT; Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO Box 22700, 1105 AZ Amsterdam, The Netherlands., Ebus ME; Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO Box 22700, 1105 AZ Amsterdam, The Netherlands., Koster J; Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO Box 22700, 1105 AZ Amsterdam, The Netherlands., den Hartog IJ; Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO Box 22700, 1105 AZ Amsterdam, The Netherlands., Zwijnenburg DA; Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO Box 22700, 1105 AZ Amsterdam, The Netherlands., Schild L; Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO Box 22700, 1105 AZ Amsterdam, The Netherlands., van der Ploeg I; Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO Box 22700, 1105 AZ Amsterdam, The Netherlands., Dolman ME; Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO Box 22700, 1105 AZ Amsterdam, The Netherlands., Caron HN; Department of Paediatric Oncology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO Box 22700, 1105 AZ Amsterdam, The Netherlands., Versteeg R; Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO Box 22700, 1105 AZ Amsterdam, The Netherlands., Molenaar JJ; Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO Box 22700, 1105 AZ Amsterdam, The Netherlands. Electronic address: j.j.molenaar@amc.uva.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2014 Feb; Vol. 50 (3), pp. 628-37. Date of Electronic Publication: 2013 Dec 06.
Autor:
Dolman ME; Amsterdam Medical Center, University of Amsterdam, Department of Oncogenomics, Meibergdreef 15, PO Box 22700, 1105 AZ Amsterdam, The Netherlands., den Hartog IJ, Molenaar JJ, Schellens JH, Beijnen JH, Sparidans RW
Publikováno v:
Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2014 Jan; Vol. 88, pp. 216-20. Date of Electronic Publication: 2013 Sep 12.
Autor:
Lamers F; Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO Box 22700, 1105 AZ Amsterdam, The Netherlands., Schild L, den Hartog IJ, Ebus ME, Westerhout EM, Ora I, Koster J, Versteeg R, Caron HN, Molenaar JJ
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2012 Nov; Vol. 48 (16), pp. 3093-103. Date of Electronic Publication: 2012 Feb 25.
Autor:
Eijkelkamp N; Laboratory of Psychoneuroimmunology, University Medical Center Utrecht, 3584 EA Utrecht, The Netherlands., Heijnen CJ, Willemen HL, Deumens R, Joosten EA, Kleibeuker W, den Hartog IJ, van Velthoven CT, Nijboer C, Nassar MA, Dorn GW 2nd, Wood JN, Kavelaars A
Publikováno v:
The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2010 Feb 10; Vol. 30 (6), pp. 2138-49.